SITC Archive Library

The Society for Immunotherapy of Cancer (SITC) 28^th Annual Meeting: Primmer on Tumor Immunology and Cancer Immunotherapy^TM
November 7, 2013
Gayloard National Hotel & Convention Center
National Harbor, MD

Program Organizers
Charles G. Drake, MD, PhD - Johns Hopkins University
Padmanee Sharma, MD, PhD - MD Anderson Cancer Center

Program Summary
The SITC Primer on Tumor Immunology and Cancer Immunotherapy™ is designed to provide a foundation for understanding core immunology principles as they relate to basic and clinical research in immunotherapy of cancer. The audience for this annual, one-day educational program includes students, postdoctoral fellows, and technicians from academia and industry, as well as physicians and scientists at more senior levels who wish to solidify their understanding of tumor immunology and immunotherapy.

The 2013 program began with a brief but up-to-date review of the immune system. Then, prominent investigators summarized central themes in cancer immunotherapy, including adoptive T cell transfer, monoclonal antibody therapy, cancer vaccines and immune checkpoint blockade. An overview of current immune monitoring techniques was also provided, in addition to a discussion on the use of pre-surgical trials to assess the immune response to experimental agents. These topics were also addressed in a series of lectures by thought leaders in the field and through interactive question and answer sessions.

Target Audience
The audience for this annual, one-day educational program includes students, postdoctoral fellows, and technicians from academia and industry, as well as physicians and scientists at more senior levels who wish to solidify their understanding of tumor immunology and immunotherapy.

Presentations and video recordings are available based on permission from presenters.